Maintaining resting cardiac fibroblasts in vitro by disrupting mechanotransduction is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
H2020 Marie Skłodowska-Curie Actions
Grant: 795390
Rho GTPase cross-talk with syndecan-4 regulates pro-fibrotic mechanotransduction in the heart
National Institutes of Health
Grant: 1 R01 HL137100-01, U01 H127654 and 1 U01 HL126273
NHLBI NIH HHS
Grant: U01 HL126273
NHLBI NIH HHS
Grant: R01 HL121754
NHLBI NIH HHS
Grant: U01 HL127654
NHLBI NIH HHS
Grant: R01 HL137100
National Institutes of Health
Grant: 5U01HL127654-03
Multiscale Models of Cardiac Growth, Remodeling, and Myocardial Infarction
National Institutes of Health
Grant: 5U01HL126273-04
Predictive multiscale in silico cardio-pharmacology
National Institutes of Health
Grant: 5R01HL137100-03
Systems Biology of Hypertrophic Heart Disease from Molecular Pathways to Organ System
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals